Switch to:
Also traded in: Canada, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.29
HLTH's Cash-to-Debt is ranked lower than
56% of the 257 Companies
in the Global Medical Care industry.

( Industry Median: 0.40 vs. HLTH: 0.29 )
Ranked among companies with meaningful Cash-to-Debt only.
HLTH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.08  Med: 2.49 Max: No Debt
Current: 0.29
Equity-to-Asset 0.47
HLTH's Equity-to-Asset is ranked higher than
51% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. HLTH: 0.47 )
Ranked among companies with meaningful Equity-to-Asset only.
HLTH' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.27  Med: 0.42 Max: 0.74
Current: 0.47
-0.27
0.74
Interest Coverage 2.51
HLTH's Interest Coverage is ranked lower than
82% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 8.17 vs. HLTH: 2.51 )
Ranked among companies with meaningful Interest Coverage only.
HLTH' s Interest Coverage Range Over the Past 10 Years
Min: 2.51  Med: N/A Max: No Debt
Current: 2.51
Piotroski F-Score: 3
Altman Z-Score: 1.49
Beneish M-Score: -2.34
WACC vs ROIC
1.30%
3.20%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 3.51
HLTH's Operating Margin % is ranked lower than
71% of the 255 Companies
in the Global Medical Care industry.

( Industry Median: 7.71 vs. HLTH: 3.51 )
Ranked among companies with meaningful Operating Margin % only.
HLTH' s Operating Margin % Range Over the Past 10 Years
Min: -13.69  Med: 14.3 Max: 64.77
Current: 3.51
-13.69
64.77
Net Margin % 2.26
HLTH's Net Margin % is ranked lower than
67% of the 256 Companies
in the Global Medical Care industry.

( Industry Median: 4.84 vs. HLTH: 2.26 )
Ranked among companies with meaningful Net Margin % only.
HLTH' s Net Margin % Range Over the Past 10 Years
Min: -243.59  Med: 2.85 Max: 22.18
Current: 2.26
-243.59
22.18
ROE % 4.92
HLTH's ROE % is ranked lower than
71% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 9.89 vs. HLTH: 4.92 )
Ranked among companies with meaningful ROE % only.
HLTH' s ROE % Range Over the Past 10 Years
Min: -141.14  Med: -3.11 Max: 61.25
Current: 4.92
-141.14
61.25
ROA % 2.58
HLTH's ROA % is ranked lower than
62% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 4.66 vs. HLTH: 2.58 )
Ranked among companies with meaningful ROA % only.
HLTH' s ROA % Range Over the Past 10 Years
Min: -96.85  Med: 2.79 Max: 29.27
Current: 2.58
-96.85
29.27
ROC (Joel Greenblatt) % 17.24
HLTH's ROC (Joel Greenblatt) % is ranked lower than
53% of the 257 Companies
in the Global Medical Care industry.

( Industry Median: 21.13 vs. HLTH: 17.24 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
HLTH' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -61.1  Med: 73.21 Max: 269.5
Current: 17.24
-61.1
269.5
3-Year Revenue Growth Rate 63.90
HLTH's 3-Year Revenue Growth Rate is ranked higher than
99% of the 183 Companies
in the Global Medical Care industry.

( Industry Median: 8.50 vs. HLTH: 63.90 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
HLTH' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -48.5  Med: -6.95 Max: 205.5
Current: 63.9
-48.5
205.5
3-Year EBITDA Growth Rate 13.40
HLTH's 3-Year EBITDA Growth Rate is ranked higher than
64% of the 161 Companies
in the Global Medical Care industry.

( Industry Median: 8.10 vs. HLTH: 13.40 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
HLTH' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -53.8  Med: 10.3 Max: 126.2
Current: 13.4
-53.8
126.2
3-Year EPS without NRI Growth Rate 26.00
HLTH's 3-Year EPS without NRI Growth Rate is ranked higher than
78% of the 139 Companies
in the Global Medical Care industry.

( Industry Median: 8.40 vs. HLTH: 26.00 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
HLTH' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -78.9  Med: 26 Max: 223.8
Current: 26
-78.9
223.8
GuruFocus has detected 5 Warning Signs with Nobilis Health Corp $HLTH.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» HLTH's 10-Y Financials

Financials (Next Earnings Date: 2017-05-02)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

HLTH Guru Trades in Q1 2016

Jim Simons 157,500 sh (+64.75%)
Chuck Royce 1,235,700 sh (+28.62%)
» More
Q2 2016

HLTH Guru Trades in Q2 2016

Chuck Royce 1,590,800 sh (+28.74%)
Jim Simons Sold Out
» More
Q3 2016

HLTH Guru Trades in Q3 2016

Jim Simons 33,500 sh (New)
Chuck Royce 1,515,800 sh (-4.71%)
» More
Q4 2016

HLTH Guru Trades in Q4 2016

Jim Simons Sold Out
Chuck Royce 1,465,800 sh (-3.30%)
» More
» Details

Insider Trades

Latest Guru Trades with HLTH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621999    SIC: 8619
Compare:OTCPK:MIHI, NYSE:QHC, OTCPK:AMEH, NAS:JYNT, NAS:CATS, OTCPK:FCHS, OTCPK:BICX, OTCPK:CCEL, AMEX:AMS, NYSE:AAC, OTCPK:CVHIF, OTCPK:BNKL, OTCPK:JRSS, OTCPK:CAMDF, AMEX:SSY, OTCPK:ADPTQ, OTCPK:PFHO, NAS:BIOS, OTCPK:WNDM, AMEX:HH » details
Traded in other countries:NHC.Canada, NH1.Germany,
Headquarter Location:USA
Nobilis Health Corp is a full-service healthcare development and management company, with 25 locations in seven states, including 4 hospitals, 10 ASCs and 11 clinics. In addition, it partners with another 38 facilities across the country.

Northstar Healthcare, Inc. partners with the physicians in the development and management of ambulatory surgery centres in the United States. It manages an ambulatory surgery centre in Dallas and two pain management clinics in Houston.

Top Ranked Articles about Nobilis Health Corp

Nobilis Health Announces Results of 2016 Annual General Meeting of Shareholders

HOUSTON, TX--(Marketwired - Jun 28, 2016) - Nobilis Health Corp. ("Nobilis" or the "Company") (NYSE MKT: HLTH) (TSX: NHC) today announced the director election results from its 2016 annual general meeting of shareholders held on June 28, 2016 (the "Meeting"). A ballot was conducted with respect to the election of the directors to hold office until the next annual meeting of shareholders. According to the proxies received and ballots cast, the following directors were elected to hold office until the next annual meeting of shareholders or until their successors are elected or appointed, unless such office is earlier vacated in accordance with the articles of the Company:


 
 
 
 
 
 
 
 
 


Nominee
 
# Votes For
 
% Votes For
 
# Votes Withheld
 
% Votes Withheld


Steve Ozonian
 
31,145,887
 
89.50
 
3,654,053
 
10.50


Richard Ganley
 
10,558,181
 
30.34
 
24,241,759
 
69.66


Jennifer Hauser
 
8,582,262
 
24.66
 
26,217,678
 
75.34


Dr. Donald Kramer
 
34,712,009
 
99.75
 
87,931
 
0.25


Tom Foster
 
34,596,202
 
99.41
 
203,738
 
0.59


Peter Horan
 
34,720,109
 
99.77
 
79,831
 
0.23


Michael C. Nichols
 
34,720,409
 
99.77
 
79,531
 
0.23


 
 
 
 
 
 
 
 
 



As Mr. Ganley and Ms. Hauser did not receive the requisite majority of votes "FOR" their election as directors at the Meeting, per the Company's Majority Voting Policy, Mr. Ganley and Ms. Hauser have tendered their resignations as directors of the Company. The board of directors of the Company (the "Board"), pursuant to the terms of the Company's Majority Voting Policy, reviewed, considered and accepted such resignations. The Board wishes to thank Mr. Ganley and Ms. Hauser for their service as directors. Shareholders also voted in favor of setting the number of directors at seven for the ensuing year, ratifying and approving the Company's Advance Notice Policy and appointing Crowe Horwath LLP as auditor of the Company. For further information regarding the voting results for matters considered and approved by the shareholders at the Meeting, please see the Company's report of voting results that has been filed on SEDAR at www.sedar.com and the Company's Current Report on Form 8-K that has been filed on EDGAR at www.sec.gov. About Nobilis Health Corp. Nobilis (www.NobilisHealth.com) is a full-service healthcare development and management company which currently owns or manages four surgical hospitals and five ASCs, partners with thirty-three additional facilities throughout the country, and markets six independent brands. Deploying a unique patient acquisition strategy driven by direct-to-consumer marketing, Nobilis is focused on a specified set of procedures that are performed at our centers by local physicians. Cautionary Statement Regarding Forward-Looking Information This news release contains forward-looking statements (within the meaning of applicable securities laws) and financial outlooks relating to the business of the Company and the environment in which it operates. Forward-looking statements are identified by words such as "believe", "anticipate", "expect", "intend", "plan", "will", "may" and other similar expressions. Some of the forward-looking statements relate to management changes. This risk, and other risks and uncertainties, may cause results to differ materially from those set forth in the forward-looking statements. Additional risks and uncertainties are further discussed in the Company's regulatory filings available on the Company's web site at www.NobilisHealth.com, www.Sedar.com, and www.sec.gov in the risk factors described in the Company's Form 10-K for the fiscal year ended December 31, 2015, filed on March 15, 2016. There can be no assurance that forward-looking statements will prove to be accurate as actual outcomes and results may differ materially from those expressed in these forward-looking statements. Readers, therefore, should not place undue reliance on any such forward-looking statements. Further, a forward-looking statement speaks only as of the date on which such statement is made. Other than as required by law, the Company undertakes no obligation to publicly update any such statement or to reflect new information or the occurrence of future events or circumstances.


Contact Information:



Kolin Ozonian

Vice President, Corporate Development

[email protected]

713-355-8614





Read more...
Nobilis Announces Board Nominations for June 28th Shareholder Meeting

HOUSTON, TX--(Marketwired - May 26, 2016) - Nobilis Health Corp. (NYSE MKT: HLTH) (TSX: NHC) ("Nobilis" or the "Company") announced today three independent board nominations for election to its board of directors: Peter Horan, Mike Nichols, and Tom Foster. In addition, existing directors Steve Ozonian, Don Kramer, Jennifer Hauser, and Rich Ganley are standing for re-election to the company's board of directors. Harry Fleming will not stand for reelection but will continue as the Company's Chief Executive Officer. The proposed slate will be presented for election at the company's annual shareholders meeting on June 28, 2016. "After an intensive search and review process, we have recruited an impressive and diverse slate of board nominees to advise the company as we continue to grow," said Mr. Fleming. "Peter Horan is a successful entrepreneur and a pioneer in the digital media space, Mike Nichols is the former chief operating officer and general counsel for Sysco Foods, and Tom Foster is a former Nobilis Board Member and retired international tax attorney from Exxon Mobil," continued Mr. Fleming. "In addition to our immensely qualified new board nominees, the board has taken steps to safeguard shareholder value through the addition of an Advance Notice Policy as described in yesterday's press release," said Steve Ozonian, chairman of the board of Nobilis Health. "The board is committed to protecting shareholders from any predatory takeover actions. We believe that the best way forward is to continue to support management's execution of strategy." If elected, Nobilis' board of directors will consist of seven members including existing directors Steve Ozonian, Nobilis chairman; Dr. Donald Kramer, Jennifer Hauser, Rich Ganley, and new additions Peter Horan, Mike Nichols, and Thomas Foster. About Nobilis Health Corp.

Nobilis (www.NobilisHealth.com) is a full-service healthcare development and management company which currently owns or manages four surgical hospitals and five ASCs, partners with thirty-three additional facilities throughout the country, and markets six independent brands. Deploying a unique patient acquisition strategy driven by direct-to-consumer marketing, Nobilis is focused on a specified set of procedures that are performed at our centers by local physicians. Cautionary Statement Regarding Forward-Looking Information

This news release contains forward-looking statements (within the meaning of applicable securities laws) and financial outlooks relating to the business of the Company and the environment in which it operates. Forward-looking statements are identified by words such as "believe", "anticipate", "expect", "intend", "plan", "will", "may" and other similar expressions. Some of the forward-looking statements relate to management changes. This risk, and other risks and uncertainties, may cause results to differ materially from those set forth in the forward-looking statements. Additional risks and uncertainties are further discussed in the Company's regulatory filings available on the Company's web site at www.NobilisHealth.com, www.Sedar.com, andwww.sec.gov in the risk factors described in the Company's Form 10-K for the fiscal year ended December 31, 2015, filed on March 15, 2016. There can be no assurance that forward-looking statements will prove to be accurate as actual outcomes and results may differ materially from those expressed in these forward-looking statements. Readers, therefore, should not place undue reliance on any such forward-looking statements. Further, a forward-looking statement speaks only as of the date on which such statement is made. Other than as required by law, the Company undertakes no obligation to publicly update any such statement or to reflect new information or the occurrence of future events or circumstances.


Contact Information:


Kolin Ozonian

Vice President, Corporate Development

[email protected]

713-355-8614





Read more...
Nobilis Health Corp. Announces Advance Notice Policy

HOUSTON, TX--(Marketwired - May 25, 2016) - Nobilis Health Corp. ("Nobilis" or the "Company") (TSX: NHC) (NYSE MKT: HLTH) announces that the board of directors (the "Board") of the Company approved an advance notice policy (the "Advance Notice Policy) on May 24, 2016. The Advance Notice Policy includes, among other things, a provision that requires advance notice be given to the Company in circumstances where nominations of persons for election to the Board are made by shareholders of the Company. This policy also sets a deadline by which director nominations must be submitted to the Company prior to any annual or special meeting of the shareholders and also sets out the required information that must be included in the notice to the Company. In the case of an annual meeting of the shareholders, notice to the Company must be made not less than 30 days. If the annual meeting is being held on a date that is less than 50 days after the date (the "Notice Date") on which the first public announcement of the meeting was made, notice may be made not later than the close of business on the 10th day following (i) the date of the public announcement of the Advance Notice Policy, with respect to the 2016 annual meeting of shareholders; or (ii) the Notice Date in respect of any subsequent annual meeting of shareholders.  In the case of a special meeting (which is not also an annual meeting) of shareholders called for the purpose of electing directors (whether or not called for other purposes), notice to the Company must be made not later than the close of business on the 15th day following the day on which the first public announcement of the date of the special meeting was made. Notwithstanding the foregoing, the board of directors may, in its sole discretion, waive any requirement of the Advance Notice Policy. The Advance Notice Policy is now effective in full force and effect and will apply in connection with the Company's 2016 annual general meeting of shareholders (the "Shareholders' Meeting"). The Company intends to seek shareholder approval and ratification of the Advance Notice Policy at the Shareholders' Meeting. If the Advance Notice Policy is not approved by ordinary resolution of the Company's shareholders present in person or voting by proxy at the Shareholders' Meeting, then it will terminate and be void and of no further force and effect following the termination of the Shareholders' Meeting.  For purposes of the Meeting, in accordance with the terms of the Advance Notice Policy, the Board has determined that notice of nominations of persons for election to the Board at the Meeting must be made by June 4, 2016. Such notice must be in the form, and given in the manner, prescribed by the Advance Notice Policy, and Matthew Maruca, the Corporate Secretary of the Company, has stipulated [email protected] as an email address for receipt of such a notice. The full text of the Advance Notice Policy is available on EDGAR at www.sec.gov. About Nobilis Health Corp. Nobilis utilizes innovative direct-to-patient marketing focused on a specified set of procedures that are performed at our centers by local physicians. Currently, Nobilis owns and manages four surgical hospitals and five ambulatory surgical centers, partners with an additional 28 facilities throughout the country, and markets six independent brands. Cautionary Statement Regarding Forward-Looking Information This news release contains forward-looking statements (within the meaning of applicable securities laws) and financial outlooks relating to the business of the Company and the environment in which it operates. Forward-looking statements are identified by words such as "believe", "anticipate", "expect", "intend", "plan", "will", "may" and other similar expressions. Some of the forward-looking statements relate to management changes. This risk, and other risks and uncertainties, may cause results to differ materially from those set forth in the forward-looking statements. Additional risks and uncertainties are further discussed in the Company's regulatory filings available on the Company's web site at www.NobilisHealth.com, www.Sedar.com, and www.sec.gov in the risk factors described in the Company's Form 10-K for the fiscal year ended December 31, 2015, filed on March 15, 2016. There can be no assurance that forward-looking statements will prove to be accurate as actual outcomes and results may differ materially from those expressed in these forward-looking statements. Readers, therefore, should not place undue reliance on any such forward-looking statements. Further, a forward-looking statement speaks only as of the date on which such statement is made. Other than as required by law, the Company undertakes no obligation to publicly update any such statement or to reflect new information or the occurrence of future events or circumstances.


Contact Information:


Kolin Ozonian

Vice President, Corporate Development

[email protected]

713-355-8614





Read more...
Nobilis to Participate in the 13th Annual Craig-Hallum Institutional Investor Conference

HOUSTON, TX--(Marketwired - May 23, 2016) - Nobilis Health Corp. (NYSE MKT: HLTH) (TSX: NHC) ("Nobilis" or the "Company") announced today that management will participate in the 13th Annual Craig-Hallum Institutional Investor Conference on Wednesday, June 1, 2016. The conference will be held at the Depot Renaissance Minneapolis Hotel in Minneapolis, MN. The conference consists of a full day of one-on-one meetings and will not be webcast. Investors interested in arranging one-on-one meetings should contact their Craig-Hallum sales representative. About Nobilis Health Corp.

Nobilis (www.NobilisHealth.com) is a full-service healthcare development and management company which currently owns or manages four surgical hospitals and five ASCs, partners with an additional thirty-three facilities throughout the country, and markets six independent brands. Deploying a unique patient acquisition strategy driven by direct-to-consumer marketing, Nobilis is focused on a specified set of procedures that are performed at our centers by local physicians. Forward-Looking Statements This press release contains certain forward-looking statements within the meaning of Canadian and United States securities laws, including the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and may be identified by the use of words such as "may," "believe," "will," "expect," "project," "estimate," "anticipate," "plan" or "continue." These forward-looking statements are based on current plans and expectations and are subject to a number of risks, uncertainties and other factors which could significantly affect current plans and expectations and our future financial condition and results. These factors, which could cause actual results, performance and achievements to differ materially from those anticipated, include, but are not limited to the risk that we may face challenges managing our new Marketing Segment and may not realize anticipated benefits; our ability to successfully maintain effective internal controls over financial reporting; our ability to implement our business strategy, manage the growth in our business, and integrate acquired businesses; the risk of litigation and investigations, and liability claims for damages and other expenses not covered by insurance; the risk that payments from third-party payers, including government healthcare programs, may decrease or not increase as costs increase; adverse developments affecting the medical practices of our physician limited partners; our ability to maintain favorable relations with our physician limited partners; our ability to grow revenues by increasing case and procedure volume while maintaining profitability at the Nobilis Facilities; failure to timely or accurately bill for services; our ability to compete for physician partners, patients and strategic relationships; the risk of changes in patient volume and patient mix; the risk that laws and regulations that regulate payments for medical services made by government healthcare programs could cause our revenues to decrease; the risk that contracts are cancelled or not renewed or that we are not able to enter into additional contracts under terms that are acceptable to us; and the risk of potential decreases in our reimbursement rates. The foregoing are significant factors we think could cause our actual results to differ materially from expected results. However, there could be additional factors besides those listed herein that also could affect us in an adverse manner. We have not undertaken any obligation to publicly update or revise any forward-looking statements. All of our forward-looking statements speak only as of the date of the document in which they are made or, if a date is specified, as of such date. Subject to a mandatory requirements of applicable law, we disclaim any obligation or undertaking to provide any updates or revisions to any forward-looking statement to reflect any change in our expectations or any changes in events, conditions, circumstances or information on which the forward-looking statement is based. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing factors and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015, filed on March 15, 2016, as updated by other filings with the Securities and Exchange Commission.


Contact Information:


Kolin Ozonian

Vice President, Corporate Development

[email protected]

713-355-8614





Read more...
Nobilis Health Corp. Appoints Chief Accounting Officer

HOUSTON, TX--(Marketwired - May 16, 2016) - Nobilis Health Corp. (NYSE MKT: HLTH) (TSX: NHC) ("Nobilis" or the "Company") today announced the appointment of Marcos Rodriguez as Chief Accounting Officer of the Company. Mr. Rodriguez brings over 17 years of diversified accounting experience to the Company. Prior to joining Nobilis, Mr. Rodriguez served for five years as Director in Complex Financial Reporting and Enterprise Risk at Opportune LLP, and 11 years at Deloitte & Touche as Audit Senior Manager in Audit & Enterprise Risk Services. Mr. Rodriguez's experience includes financial accounting and reporting, technical accounting research, external and internal audits, initial public offering readiness, Sarbanes-Oxley implementations, mergers and acquisitions, Securities and Exchange Commission regulations, and both U.S. Generally Accepted Accounting Principles and International Financial Reporting Standards. Mr. Rodriguez graduated with a B.S. in accounting from Louisiana State University and is a certified public accountant. "Nobilis is exceptionally fortunate to be able to attract a professional of Marcos' caliber," said Harry Fleming, Chief Executive Officer of Nobilis. "As we continue our transition from a micro-cap company to small-cap enterprise, Marcos will be invaluable in bringing a new level of sophistication and transparency to our accounting department. These improvements will allow us to keep pace with the incredible growth we have experienced in the past several years." About Nobilis Health Corp. Nobilis (www.NobilisHealth.com) is a full-service healthcare development and management company which currently owns or manages four surgical hospitals and five ASCs, partners with an additional thirty-three facilities throughout the country, and markets six independent brands. Deploying a unique patient acquisition strategy driven by direct-to-consumer marketing, Nobilis is focused on a specified set of procedures that are performed at our centers by local physicians. Forward-Looking Statements This press release contains certain forward-looking statements within the meaning of Canadian and United States securities laws, including the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and may be identified by the use of words such as "may," "believe," "will," "expect," "project," "estimate," "anticipate," "plan" or "continue." These forward-looking statements are based on current plans and expectations and are subject to a number of risks, uncertainties and other factors which could significantly affect current plans and expectations and our future financial condition and results. These factors, which could cause actual results, performance and achievements to differ materially from those anticipated, include, but are not limited to the risk that we may face challenges managing our new Marketing Segment and may not realize anticipated benefits; our ability to successfully maintain effective internal controls over financial reporting; our ability to implement our business strategy, manage the growth in our business, and integrate acquired businesses; the risk of litigation and investigations, and liability claims for damages and other expenses not covered by insurance; the risk that payments from third-party payers, including government healthcare programs, may decrease or not increase as costs increase; adverse developments affecting the medical practices of our physician limited partners; our ability to maintain favorable relations with our physician limited partners; our ability to grow revenues by increasing case and procedure volume while maintaining profitability at the Nobilis Facilities; failure to timely or accurately bill for services; our ability to compete for physician partners, patients and strategic relationships; the risk of changes in patient volume and patient mix; the risk that laws and regulations that regulate payments for medical services made by government healthcare programs could cause our revenues to decrease; the risk that contracts are cancelled or not renewed or that we are not able to enter into additional contracts under terms that are acceptable to us; and the risk of potential decreases in our reimbursement rates. The foregoing are significant factors we think could cause our actual results to differ materially from expected results. However, there could be additional factors besides those listed herein that also could affect us in an adverse manner. We have not undertaken any obligation to publicly update or revise any forward-looking statements. All of our forward-looking statements speak only as of the date of the document in which they are made or, if a date is specified, as of such date. Subject to a mandatory requirements of applicable law, we disclaim any obligation or undertaking to provide any updates or revisions to any forward-looking statement to reflect any change in our expectations or any changes in events, conditions, circumstances or information on which the forward-looking statement is based. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing factors and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015, filed on March 15, 2016, as updated by other filings with the Securities and Exchange Commission.


Contact Information:

Kolin Ozonian

Vice President

Corporate Development

[email protected]

713-355-8614





Read more...
Nobilis Financial Update

HOUSTON, TX--(Marketwired - May 12, 2016) -  Nobilis Health Corp. ("Nobilis" or the "Company") (NYSE MKT: HLTH) (TSX: NHC) is announcing an updated timing of its release of its Quarterly Report on Form 10-Q for the three months ended March 31, 2016 (the "Q1 10-Q"). The Company and its independent registered public accounting firm, Crowe Horwath LLP, are expeditiously working to obtain technical confirmation on accounting treatment of two narrow, non-cash accounting entries. Management believes the Q1 10-Q will be released shortly. The Company has filed a Form 12b-25, Notification of Late Filing, with the U.S. Securities and Exchange Commission with regard to the Q1 10-Q, which grants the Company an extension of time until Monday March 16th to timely file the Q1 10-Q. Forward Looking Statements This press release contains certain forward-looking statements within the meaning of Canadian and United States securities laws, including the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and may be identified by the use of words such as "may," "believe," "will," "expect," "project," "estimate," "anticipate," "plan" or "continue." These forward-looking statements are based on current plans and expectations and are subject to a number of risks, uncertainties and other factors which could significantly affect current plans and expectations and our future financial condition and results. These factors, which could cause actual results, performance and achievements to differ materially from those anticipated, include, but are not limited to the risk that we may face challenges managing our new Marketing Segment and Concertis and may not realize anticipated benefits; our ability to successfully maintain effective internal controls over financial reporting; our ability to implement our business strategy, manage the growth in our business, and integrate acquired businesses; the risk of litigation and investigations, and liability claims for damages and other expenses not covered by insurance; the risk that payments from third-party payers, including government healthcare programs, may decrease or not increase as costs increase; adverse developments affecting the medical practices of our physician limited partners; our ability to maintain favorable relations with our physician limited partners; our ability to grow revenues by increasing case and procedure volume while maintaining profitability at the Nobilis Facilities; failure to timely or accurately bill for services; our ability to compete for physician partners, patients and strategic relationships; the risk of changes in patient volume and patient mix; the risk that laws and regulations that regulate payments for medical services made by government healthcare programs could cause our revenues to decrease; the risk that contracts are cancelled or not renewed or that we are not able to enter into additional contracts under terms that are acceptable to us; and the risk of potential decreases in our reimbursement rates. The foregoing are significant factors we think could cause our actual results to differ materially from expected results. However, there could be additional factors besides those listed herein that also could affect us in an adverse manner. We have not undertaken any obligation to publicly update or revise any forward-looking statements. All of our forward-looking statements speak only as of the date of the document in which they are made or, if a date is specified, as of such date. Subject to an mandatory requirements of applicable law, we disclaim any obligation or undertaking to provide any updates or revisions to any forward-looking statement to reflect any change in our expectations or any changes in events, conditions, circumstances or information on which the forward-looking statement is based. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing factors and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015, filed on March 15, 2016, as updated by other filings with the Securities and Exchange Commission. About Nobilis Health Corp.

Nobilis (www.NobilisHealth.com) is a full-service healthcare development and management company which currently owns or manages four surgical hospitals and five ASCs, partners with an additional thirty-three facilities throughout the country, and markets six independent brands. Deploying a unique patient acquisition strategy driven by direct-to-consumer marketing, Nobilis is focused on a specified set of procedures that are performed at our centers by local physicians.


Kolin Ozonian

Vice President, Corporate Development

[email protected]

713-355-8614





Read more...
Nobilis First Quarter 2016 Earnings Release Date & Conference Call

HOUSTON, TX--(Marketwired - May 4, 2016) - Nobilis Health Corp. (NYSE MKT: HLTH) (TSX: NHC) ("Nobilis" or the "Company") will release its first quarter 2016 financials on Tuesday, May 10, 2016 after market close and the earnings call will be held on Wednesday, May 11, 2016 at 8:00 a.m. Central Time.  Dial-in and streaming information will be provided in a subsequent press release. About Nobilis Health Corp. Nobilis (www.NobilisHealth.com) is a full-service healthcare development and management company which currently owns or manages four surgical hospitals and five ASCs, partners with an additional thirty-three facilities throughout the country, and markets six independent brands. Deploying a unique patient acquisition strategy driven by direct-to-consumer marketing, Nobilis is focused on a specified set of procedures that are performed at our centers by local physicians. Forward-Looking Statements This press release contains certain forward-looking statements within the meaning of Canadian and United States securities laws, including the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and may be identified by the use of words such as "may," "believe," "will," "expect," "project," "estimate," "anticipate," "plan" or "continue." These forward-looking statements are based on current plans and expectations and are subject to a number of risks, uncertainties and other factors which could significantly affect current plans and expectations and our future financial condition and results. These factors, which could cause actual results, performance and achievements to differ materially from those anticipated, include, but are not limited to the risk that we may face challenges managing our new Marketing Segment and may not realize anticipated benefits; our ability to successfully maintain effective internal controls over financial reporting; our ability to implement our business strategy, manage the growth in our business, and integrate acquired businesses; the risk of litigation and investigations, and liability claims for damages and other expenses not covered by insurance; the risk that payments from third-party payers, including government healthcare programs, may decrease or not increase as costs increase; adverse developments affecting the medical practices of our physician limited partners; our ability to maintain favorable relations with our physician limited partners; our ability to grow revenues by increasing case and procedure volume while maintaining profitability at the Nobilis Facilities; failure to timely or accurately bill for services; our ability to compete for physician partners, patients and strategic relationships; the risk of changes in patient volume and patient mix; the risk that laws and regulations that regulate payments for medical services made by government healthcare programs could cause our revenues to decrease; the risk that contracts are cancelled or not renewed or that we are not able to enter into additional contracts under terms that are acceptable to us; and the risk of potential decreases in our reimbursement rates. The foregoing are significant factors we think could cause our actual results to differ materially from expected results. However, there could be additional factors besides those listed herein that also could affect us in an adverse manner. We have not undertaken any obligation to publicly update or revise any forward-looking statements. All of our forward-looking statements speak only as of the date of the document in which they are made or, if a date is specified, as of such date. Subject to a mandatory requirements of applicable law, we disclaim any obligation or undertaking to provide any updates or revisions to any forward-looking statement to reflect any change in our expectations or any changes in events, conditions, circumstances or information on which the forward-looking statement is based. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing factors and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015, filed on March 15, 2016, as updated by other filings with the Securities and Exchange Commission.


Contact Information:



Kolin Ozonian

Vice President, Corporate Development

(713) 355-8614

[email protected]





Read more...
Nobilis Health Corp. Launches Bundled-Payment and Health Technology Initiative With Formation of Concertis, LLC

HOUSTON, TX--(Marketwired - May 2, 2016) - Nobilis Health Corp. (NYSE MKT: HLTH) (TSX: NHC) ("Nobilis" or the "Company") announced today that it has launched Concertis, LLC ("Concertis"), a 100% Nobilis-owned entity. Concertis is a comprehensive technology platform that will develop new payment and delivery methodologies to enhance value for patients, payers, and providers across the continuum of care. Marissa W. Arreola, a former health law partner at the firm Baker Donelson, will lead this division as its president. "Concertis' proprietary technology platform coupled with its commitment to developing unique bundled payment networks will result in high quality health care without the financial and administrative burdens of traditional fee-for service model," said Ms. Arreola. Clinical Integration Network Formation and Administration

Concertis will align independent physicians and health care facilities with payers to offer alternatives to the traditional fee-for-service model. The company will negotiate with payers (insurance companies and self-insured employers) to combine reimbursement for multiple providers and facilities into a single comprehensive bundled payment that covers all of the services involved in a patient's episode of care. This clinical integration strategy will result in improved patient outcomes, integrated care, expense savings, and enhanced revenue. The bundled payment component of this clinical integration product will also provide a warranty for surgical services, alleviating financial risk for payers and patients.  Population Health Management

Concertis will aggregate patient data culled from multiple platforms and analyze it to manage specific diseases and episodes of care. This powerful data tool will enable health care providers, facilities, and payers to improve clinical and financial outcomes through implementation of clinical best practices. Concertis will not only track data but will also take action by engaging patients in their treatment and recovery plans. Concertis' care navigation team will work with patients until 30-60 days following surgery, and all complications and readmissions occurring during the warranty period will be covered within the initial bundled payment, alleviating financial risk for payers and patients.  Care Coordination

Concertis' care navigators will serve as concierges to patients, guiding them through the entire episode of care to provide a personalized healthcare experience that will minimize costly post-surgical complications.  "Bundled payments and performance based healthcare are going to be the driving force of healthcare as the industry moves to more efficient and cost effective delivery of healthcare services," said Harry Fleming, Nobilis' CEO. "Nobilis is positioning itself to be at the forefront of this movement by investing in the talent and technology today. We have acquired some of the top talent in Texas in both healthcare, with Ms. Arreola, and technology, with Lee McMillian, Ph.D., Nobilis' Vice President of IT. These two executives have led the development of these types of programs at multi-billion dollar enterprises. As we roll out the Concertis model we expect it will contribute a significant number of patients to our network of physicians to supplement our proven technology based marketing model," continued Fleming. About Nobilis Health Corp.

Nobilis (www.NobilisHealth.com) is a full-service healthcare development and management company which currently owns or manages four surgical hospitals and five ASCs, partners with an additional thirty-three facilities throughout the country, and markets six independent brands. Deploying a unique patient acquisition strategy driven by direct-to-consumer marketing, Nobilis is focused on a specified set of procedures that are performed at our centers by local physicians. Forward-Looking Statements

This press release contain certain forward-looking statements within the meaning of Canadian and United States securities laws, including the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and may be identified by the use of words such as "may," "believe," "will," "expect," "project," "estimate," "anticipate," "plan" or "continue." These forward-looking statements are based on current plans and expectations and are subject to a number of risks, uncertainties and other factors which could significantly affect current plans and expectations and our future financial condition and results. These factors, which could cause actual results, performance and achievements to differ materially from those anticipated, include, but are not limited to the risk that we may face challenges managing our new Marketing Segment and may not realize anticipated benefits; our ability to successfully maintain effective internal controls over financial reporting; our ability to implement our business strategy, manage the growth in our business, and integrate acquired businesses; the risk of litigation and investigations, and liability claims for damages and other expenses not covered by insurance; the risk that payments from third-party payers, including government healthcare programs, may decrease or not increase as costs increase; adverse developments affecting the medical practices of our physician limited partners; our ability to maintain favorable relations with our physician limited partners; our ability to grow revenues by increasing case and procedure volume while maintaining profitability at the Nobilis Facilities; failure to timely or accurately bill for services; our ability to compete for physician partners, patients and strategic relationships; the risk of changes in patient volume and patient mix; the risk that laws and regulations that regulate payments for medical services made by government healthcare programs could cause our revenues to decrease; the risk that contracts are cancelled or not renewed or that we are not able to enter into additional contracts under terms that are acceptable to us; and the risk of potential decreases in our reimbursement rates. The foregoing are significant factors we think could cause our actual results to differ materially from expected results. However, there could be additional factors besides those listed herein that also could affect us in an adverse manner. We have not undertaken any obligation to publicly update or revise any forward-looking statements. All of our forward-looking statements speak only as of the date of the document in which they are made or, if a date is specified, as of such date. Subject to an mandatory requirements of applicable law, we disclaim any obligation or undertaking to provide any updates or revisions to any forward-looking statement to reflect any change in our expectations or any changes in events, conditions, circumstances or information on which the forward-looking statement is based. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing factors and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015, filed on March 15, 2016, as updated by other filings with the Securities and Exchange Commission.


Contact Information:

Kolin Ozonian

Vice President, Corporate Development

[email protected]

713-355-8614





Read more...

Ratios

vs
industry
vs
history
PE Ratio 17.86
HLTH's PE Ratio is ranked higher than
57% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. HLTH: 17.86 )
Ranked among companies with meaningful PE Ratio only.
HLTH' s PE Ratio Range Over the Past 10 Years
Min: 2.99  Med: 14 Max: 77.19
Current: 17.86
2.99
77.19
PE Ratio without NRI 17.86
HLTH's PE Ratio without NRI is ranked higher than
58% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 28.00 vs. HLTH: 17.86 )
Ranked among companies with meaningful PE Ratio without NRI only.
HLTH' s PE Ratio without NRI Range Over the Past 10 Years
Min: 2.99  Med: 14 Max: 77.19
Current: 17.86
2.99
77.19
PB Ratio 0.68
HLTH's PB Ratio is ranked higher than
91% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 2.65 vs. HLTH: 0.68 )
Ranked among companies with meaningful PB Ratio only.
HLTH' s PB Ratio Range Over the Past 10 Years
Min: 0.64  Med: 2.76 Max: 12.83
Current: 0.68
0.64
12.83
PS Ratio 0.34
HLTH's PS Ratio is ranked higher than
88% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 1.57 vs. HLTH: 0.34 )
Ranked among companies with meaningful PS Ratio only.
HLTH' s PS Ratio Range Over the Past 10 Years
Min: 0.19  Med: 0.82 Max: 3.57
Current: 0.34
0.19
3.57
Price-to-Operating-Cash-Flow 54.35
HLTH's Price-to-Operating-Cash-Flow is ranked lower than
96% of the 154 Companies
in the Global Medical Care industry.

( Industry Median: 14.15 vs. HLTH: 54.35 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
HLTH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0.45  Med: 17.63 Max: 125
Current: 54.35
0.45
125
EV-to-EBIT 10.00
HLTH's EV-to-EBIT is ranked higher than
83% of the 292 Companies
in the Global Medical Care industry.

( Industry Median: 18.39 vs. HLTH: 10.00 )
Ranked among companies with meaningful EV-to-EBIT only.
HLTH' s EV-to-EBIT Range Over the Past 10 Years
Min: -9.9  Med: 5.4 Max: 30.1
Current: 10
-9.9
30.1
EV-to-EBITDA 6.33
HLTH's EV-to-EBITDA is ranked higher than
90% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 13.46 vs. HLTH: 6.33 )
Ranked among companies with meaningful EV-to-EBITDA only.
HLTH' s EV-to-EBITDA Range Over the Past 10 Years
Min: -28.5  Med: 5 Max: 378.2
Current: 6.33
-28.5
378.2
Current Ratio 2.48
HLTH's Current Ratio is ranked higher than
81% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 1.30 vs. HLTH: 2.48 )
Ranked among companies with meaningful Current Ratio only.
HLTH' s Current Ratio Range Over the Past 10 Years
Min: 0.78  Med: 2.37 Max: 4.51
Current: 2.48
0.78
4.51
Quick Ratio 2.41
HLTH's Quick Ratio is ranked higher than
82% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 1.18 vs. HLTH: 2.41 )
Ranked among companies with meaningful Quick Ratio only.
HLTH' s Quick Ratio Range Over the Past 10 Years
Min: 0.66  Med: 2.13 Max: 4.26
Current: 2.41
0.66
4.26
Days Inventory 1.00
HLTH's Days Inventory is ranked higher than
93% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 16.88 vs. HLTH: 1.00 )
Ranked among companies with meaningful Days Inventory only.
HLTH' s Days Inventory Range Over the Past 10 Years
Min: 18.45  Med: 42.57 Max: 1996.6
Current: 1
18.45
1996.6
Days Sales Outstanding 159.61
HLTH's Days Sales Outstanding is ranked lower than
96% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 40.40 vs. HLTH: 159.61 )
Ranked among companies with meaningful Days Sales Outstanding only.
HLTH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.52  Med: 84.27 Max: 175.75
Current: 159.61
44.52
175.75
Days Payable 6.00
HLTH's Days Payable is ranked lower than
93% of the 162 Companies
in the Global Medical Care industry.

( Industry Median: 40.41 vs. HLTH: 6.00 )
Ranked among companies with meaningful Days Payable only.
HLTH' s Days Payable Range Over the Past 10 Years
Min: 34.18  Med: 53.75 Max: 19118.01
Current: 6
34.18
19118.01

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -28.30
HLTH's 3-Year Average Share Buyback Ratio is ranked lower than
87% of the 130 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. HLTH: -28.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HLTH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -37.4  Med: -26 Max: 27.4
Current: -28.3
-37.4
27.4

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 62.50
HLTH's Price-to-Net-Current-Asset-Value is ranked lower than
98% of the 54 Companies
in the Global Medical Care industry.

( Industry Median: 8.80 vs. HLTH: 62.50 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
HLTH' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 3.67  Med: 20.34 Max: 105
Current: 62.5
3.67
105
Price-to-Tangible-Book 1.58
HLTH's Price-to-Tangible-Book is ranked higher than
73% of the 187 Companies
in the Global Medical Care industry.

( Industry Median: 3.76 vs. HLTH: 1.58 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
HLTH' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.69  Med: 3.69 Max: 46.67
Current: 1.58
1.69
46.67
Price-to-Intrinsic-Value-Projected-FCF 0.74
HLTH's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
81% of the 89 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. HLTH: 0.74 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
HLTH' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.05  Med: 0.36 Max: 2.7
Current: 0.74
0.05
2.7
Price-to-Median-PS-Value 0.40
HLTH's Price-to-Median-PS-Value is ranked higher than
89% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 1.04 vs. HLTH: 0.40 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
HLTH' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.23  Med: 0.67 Max: 1.99
Current: 0.4
0.23
1.99
Price-to-Graham-Number 1.05
HLTH's Price-to-Graham-Number is ranked higher than
71% of the 123 Companies
in the Global Medical Care industry.

( Industry Median: 2.35 vs. HLTH: 1.05 )
Ranked among companies with meaningful Price-to-Graham-Number only.
HLTH' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.52  Med: 1.28 Max: 2.44
Current: 1.05
0.52
2.44
Earnings Yield (Greenblatt) % 10.00
HLTH's Earnings Yield (Greenblatt) % is ranked higher than
85% of the 334 Companies
in the Global Medical Care industry.

( Industry Median: 4.98 vs. HLTH: 10.00 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
HLTH' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 3.3  Med: 16.7 Max: 103.9
Current: 10
3.3
103.9

More Statistics

Revenue (TTM) (Mil) $285.7
EPS (TTM) $ 0.07
Beta-0.77
Short Percentage of Float9.12%
52-Week Range $1.10 - 4.66
Shares Outstanding (Mil)77.83

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 333 335 317
EPS ($) 0.37 0.37 0.39
EPS without NRI ($) 0.37 0.37 0.39
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for HLTH

Headlines

Articles On GuruFocus.com
Nobilis Health Corp. Announces First Quarter 2017 Earnings Release Date and Conference Call Details Apr 26 2017 
Nobilis Expands Footprint to Galveston County With Acquisition of Surgery Center Sep 19 2016 
Nobilis Health Announces Results of 2016 Annual General Meeting of Shareholders Jun 28 2016 
Nobilis Announces Board Nominations for June 28th Shareholder Meeting May 26 2016 
Nobilis Health Corp. Announces Advance Notice Policy May 25 2016 
Nobilis to Participate in the 13th Annual Craig-Hallum Institutional Investor Conference May 23 2016 
Nobilis Health Corp. Appoints Chief Accounting Officer May 16 2016 
Nobilis Financial Update May 12 2016 
Nobilis First Quarter 2016 Earnings Release Date & Conference Call May 04 2016 
Nobilis Health Corp. Launches Bundled-Payment and Health Technology Initiative With Formation of Con May 02 2016 

More From Other Websites
Nobilis Health Corp. Announces First Quarter 2017 Earnings Release Date and Conference Call Details Apr 26 2017
ETFs with exposure to Nobilis Health Corp. : April 19, 2017 Apr 19 2017
Nobilis to Present at 16th Annual Needham & Company's Healthcare Conference 2017 Mar 27 2017
Nobilis Health Corp. :HLTH-US: Earnings Analysis: Q4, 2016 By the Numbers : March 23, 2017 Mar 23 2017
Nobilis Health Corp. Appoints New Executive Vice President of Operations Mar 20 2017
Nobilis to Present at Oppenheimer Healthcare Conference Mar 15 2017
Post Earnings Coverage as Tenet's Q4 Results Missed Market Expectations Mar 15 2017
Nobilis Health Announces Completion of Acquisition of Hamilton Vein Center Mar 13 2017
Nobilis Health posts 4Q profit Mar 13 2017
Nobilis Health Reports Fourth Quarter 2016 Financial Results Mar 13 2017
Nobilis Health Corp. Announces Fourth Quarter and Full Year 2016 Earnings Release Date and... Mar 08 2017
Houston health care companies name new CFOs Feb 15 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)